Overall Status

Completed (1)

Recruiting (1)

Terminated (1)

Unknown status (1)

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Cytokinetics (1)

Gianluca Pontone, MD, PhD (1)

Heart Care Foundation (1)

Istituti Clinici Scientifici Maugeri SpA (1)

Collaborator

A. Manzoni Hospital (1)

Centro Cardiologico Monzino (1)

University of Lausanne Hospitals (1)

Intervention

g-csf administration (1)

omecamtiv mecarbil matrix f1 formulation (1)

omecamtiv mecarbil matrix f2 formulation (1)

omecamtiv mecarbil swellable core technology f2 (1)

placebo (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (3)

Industry (1)

Study Type

Interventional (2)

Observational (2)

left ventricular systolic dysfunction

Showing NaN - NaN of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Cied Implantation Guidelines and Cardiac Rehabilitation

Recruiting

Left Ventricular Systolic Dysfunction
Myocardial Infarction

Pavia, Italy

ICS Maugeri

Mar 15, 2023

Modified Release Oral Formulation, Left Ventricular Systolic Dysfunction, Chronic Heart Failure Trial in Worldwide (Omecamtiv

Completed

Has Results

Modified Release Oral Formulation
+6 more

Omecamtiv Mecarbil Matrix F1 Formulation
+3 more

Mobile, Alabama
+100 more

Jul 25, 2021

Anterior Acute Myocardial Infarction, Left Ventricular Systolic Dysfunction Trial in Italy (G-CSF administration)

Terminated

Anterior Acute Myocardial Infarction
Left Ventricular Systolic Dysfunction

G-CSF administration

Ancona, AN, Italy
+52 more

Feb 2, 2021

CarDiac MagnEtic Resonance for Primary Prevention Implantable

Unknown status

Heart Failure
Left Ventricular Systolic Dysfunction

Chicago, Illinois
+28 more

Jun 5, 2019